NCT05148962View on ClinicalTrials.gov

Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

May 26, 2023

Study Completion Date

May 26, 2023

Conditions
COVID-19
Interventions
BIOLOGICAL

GRT-R910

Injection administered intramuscularly

Trial Locations (3)

Unknown

University Hospitals Birmingham NHS, Birmingham

University Hospital of Leicester NHS Trust, Leicester

Manchester University, Manchester

Sponsors
All Listed Sponsors
lead

Gritstone bio, Inc.

INDUSTRY

NCT05148962 - Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers | Biotech Hunter | Biotech Hunter